DocGo Inc. Form 8-K Summary
Business Context and Reporting Period
DocGo Inc. filed this Current Report on November 10, 2022, reporting board and leadership changes. The filing is not a quarterly or annual financial report and does not provide operating results for a reporting period.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, balance sheet data, or financial guidance.
Material Changes
- The Board increased from six to seven directors and appointed Vina Leite as a Class II independent director, serving until the next Class II election and qualification of her successor.
- Ms. Leite will participate in the standard non-employee director compensation program and received approval for an initial nonqualified stock option grant under the 2021 Stock Incentive Plan. The intended grant-date value is $320,000, with the number of options based on the Black-Scholes value and an exercise price equal to the November 17, 2022 closing stock price. Vesting is in three equal annual installments.
- Effective December 31, 2022, Lee Bienstock will become President while retaining his Chief Operating Officer role.
- Effective December 31, 2022, Andre Oberholzer will become Treasurer and Executive Vice President of Capital Markets and Strategy.
- Effective December 31, 2022, Norman Rosenberg will become Chief Financial Officer and principal accounting officer of DocGo, while continuing as Chief Financial Officer of Ambulnz Holdings, LLC.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no financial outlook, guidance, material litigation, contingencies, or risk-factor updates. It states that no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K were identified for Ms. Leite or Messrs. Bienstock, Oberholzer, and Rosenberg, and that no other arrangements or understandings governed their selections.
The filing references a November 14, 2022 press release announcing the appointments and promotions. It also specifies a November 17, 2022 grant date for Ms. Leite’s stock options, dates later than the stated November 10 report date.
Investor Verification Points
- Verify the effective date and completion of the CFO and principal accounting officer transition to Norman Rosenberg.
- Verify the final number of stock options granted to Vina Leite, the Black-Scholes valuation, exercise price, and related stock-based compensation expense.
- Review the referenced November 14, 2022 press release and subsequent filings for additional details or changes.
- Consult the company’s financial statements and subsequent filings for revenue, profitability, cash flow, debt, liquidity, and guidance, none of which are provided here.